Detalhe da pesquisa
1.
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study.
Eur Radiol
; 33(4): 2809-2820, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36562786
2.
Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis.
BMC Infect Dis
; 22(1): 614, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836207
3.
Withdrawn: Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients.
Br J Clin Pharmacol
; 86(10): 2102, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627214
4.
Analysis of HCV Isolates Among the Li Ethnic in Hainan Island of South China Reveals Their HCV-6 Unique Evolution and a New Subtype.
Cell Physiol Biochem
; 50(5): 1832-1839, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396187
5.
Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Guangzhou, China: Predominance of Genotype 1b and Increasing Incidence of Genotype 6a.
Cell Physiol Biochem
; 43(2): 775-787, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950254
6.
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study.
Br J Clin Pharmacol
; 83(10): 2259-2265, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28511283
7.
Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study.
Discov Oncol
; 15(1): 68, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460053
8.
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Signal Transduct Target Ther
; 9(1): 101, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643203
9.
Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
Aliment Pharmacol Ther
; 59(5): 680-691, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155565
10.
Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.
Int Immunopharmacol
; 125(Pt A): 111019, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879230
11.
Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization.
J Cancer Res Clin Oncol
; 149(5): 1873-1882, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788728
12.
Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.
Front Immunol
; 13: 868809, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757765
13.
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
Front Oncol
; 12: 809709, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280760
14.
DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the ß-catenin pathway.
Ann Med
; 53(1): 437-447, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33729094
15.
Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study.
Ann Transl Med
; 9(18): 1412, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34733964
16.
Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients.
Ann Transl Med
; 8(18): 1187, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33241036
17.
Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Onco Targets Ther
; 13: 12683-12693, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328740
18.
Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
Front Immunol
; 11: 613946, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33488622
19.
[Antiviral and antifibrotic therapies reduce occurrence of hepatocellular carcinoma in patients with chronic hepatitis B and liver fibrosis: a 144-week prospective cohort study].
Nan Fang Yi Ke Da Xue Xue Bao
; 39(6): 633-640, 2019 Jun 30.
Artigo
em Zh
| MEDLINE | ID: mdl-31270040
20.
[Incidence and characteristics of benign liver space-occupying mass in 17 721 patients with chronic hepatitis B: a color Doppler ultrasound-based case-control study].
Nan Fang Yi Ke Da Xue Xue Bao
; 39(10): 1149-1154, 2019 Oct 30.
Artigo
em Zh
| MEDLINE | ID: mdl-31801719